http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100485249-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-34
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-34
filingDate 1997-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2005-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2005-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100485249-B1
titleOfInvention Remedy for erection failure comprising fused pyridazine compound
abstract Provides a treatment for erectile dysfunction. The active ingredient is represented by the formula (I).n n n Formula In n n n n n n n Wherein ring C means an aromatic 5-6 membered ring which may have a hetero atom, n means an integer of 1-4, R 1 represents a hydrogen atom, a halogen atom, a cyano group, and A represents a hydrogen atom , A halogen atom, an amino group which may have a substituent, and the like, X represents a group represented by the formula -N =, Y represents a formula -CO-, an amino group which may have a substituent, and the like. Minced compound or a pharmacologically acceptable salt thereof.
priorityDate 1996-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420175429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422291522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419998717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456371022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID738038
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9888568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9955887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420018441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451245749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414873628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420277387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410792880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17779694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9207
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3806114
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10656738
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3424274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421984289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10451065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456636612

Total number of triples: 54.